Evidence map›Paper›PMID 25622993›Full record

ArticleResearch in social & administrative pharmacy : RSAP

Barriers to medication use in rural underserved patients with asthma.

Henry N Young, Shada Kanchanasuwan, Elizabeth D Cox, Megan M Moreno, Nadra S Havican

Abstract read
In one paragraph

Article in Research in social & administrative pharmacy : RSAP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Global Considerations in Asthma Treatment: Management in Low Resource Settings.Advances in experimental medicine and biology · 2023
    Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Henry N YoungDepartment of Clinical and Administrative Pharmacy, University of Georgia, Athens, GA, USA. Electronic address: hnyoung@uga.edu.
Shada KanchanasuwanDepartment of Clinical and Administrative Pharmacy, University of Georgia, Athens, GA, USA.
Elizabeth D CoxDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Megan M MorenoSeattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA.
Nadra S HavicanFamily Health Center Pharmacy of Marshfield, Inc., Marshfield, WI, USA.
University of Georgia · USMarshfield Clinic · USUniversity of Washington · USUniversity of Wisconsin–Madison · US

Funding

Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
NCATS NIH HHS UL1 TR000427NCRR NIH HHS 1UL1RR025011NCRR NIH HHS UL1 RR025011
6 · The paper itself

Abstract

backgroundAsthma control is especially challenging for underserved populations. Medication use is critical to asthma control, but patients with asthma can experience barriers to using these medications.

objectivesTo assess the nature, frequency and impact of barriers to medication use in rural underserved patients with asthma.

methodsA retrospective review of documentation from pharmacists' initial consultations with asthma patients was conducted. Pharmacist classified barriers in the following categories: knowledge, beliefs and practical issues. The Asthma Control Test (ACT) was used to assess disease control. Descriptive statistics and multivariate analyses were conducted.

resultsDocumentation from 46 consultations were examined. Eighteen participants (39%) had knowledge barriers, 18 (39%) had belief barriers and 16 (35%) had practical barriers. In bivariate analyses, only belief barriers were related to significantly worse asthma control (t = 1.83, P = 0.04). Adjusted analyses found that participants with both belief and practical barriers had significantly worse asthma control (β = -3.44, P = 0.03) in comparison to others without both barriers.

conclusionsBarriers around medications beliefs were frequent and associated with worse asthma control. Programs that identify and tailor interventions to address these patient-specific barriers may improve outcomes in rural underserved patients with asthma.

Indexed as

Health Knowledge, Attitudes, PracticeRural PopulationVulnerable PopulationsAdultAnti-Asthmatic AgentsAsthmaFemaleHumansMaleMiddle AgedPharmaceutical ServicesPharmacistsRetrospective StudiesAnti-Asthmatic AgentsAsthmaMedication useRuralUnderserved

Identifiers

PMID25622993
PMCPMC4478282
OpenAlexW2053200825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.